Back to Search
Start Over
Outcomes in patients with ETV6::RUNX1or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
- Source :
- Blood; January 2025, Vol. 145 Issue: 2 p190-201, 12p
- Publication Year :
- 2025
-
Abstract
- •Among NCI high-risk patients, 93% with ETV6::RUNX1and 54% with hyperdiploid B-ALL had excellent outcomes with low-intensity therapy.•NCI high-risk patients with hyperdiploid B-ALL and slow early MRD response had worse outcomes and, therefore, require new approaches.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 145
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs67495917
- Full Text :
- https://doi.org/10.1182/blood.2024024936